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Abstract: In the present paper, the preparation of 3-hydroxy-17-dimethyl-tert-bu-
tylsilyloxy-5-azaandrostane (15) in fourteen steps is described. B-nor-17-oxoan-
drost-5-en-3-yl acetate (1)1,2 was used as the starting material, which was trans-
formed to the key intermediate of the synthesis, B-nor-17-dimethyl-tert-butylsi-
lyloxyandrost-4-en-3-yl acetate (7).
Keywords: 5-azasteroids, B-nor-17-oxoandrost-5-en-3-yl acetate, 3-hydroxy-17-di-
methyl-tert-butylsilyloxy-5-azaandrostane.
INTRODUCTION
5-Azasteroids, the nitrogen analogs of natural steroids which contain the
six-membered rings A and B, deserve particular attention. Due to their structural
similarity with non-modified steroids, it can be assumed that the 5-aza analogs of
biologically active natural steroids could also possess potential biological activity.
In connection with such a possibility, it was assumed that 3,17-dihydro-
xy-5-aza derivatives with 17-hydroxyl group protected could be useful substrates for
the preparation of the above-mentioned 5-aza derivatives. The structure of such sub-
strates enables the selective functionalization of the C(3)- and C(17)-position, which is
necessary in most of the syntheses of biologically active steroid compounds.
RESULTS AND DISCUSSION
The starting 17-oxo derivative 1 was reduced with a methanolic solution of so-
dium borohydride to produce the 17-alcohol 2 (in about 95 % yield). Upon treat-
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ment with tert-butyldimethylsilyl chloride in dimethyl formamide in the presence
of imidazole, the alcohol 2 was transformed to the crystalline tert-butyldimethyl-
silyl derivative 3 (in  97 % yield) (Scheme 1). Its 1H-NMR spectrum (singlet,
12H, at  0.86 ppm for (CH3)3C and CH3(19)), and
13C-NMR spectrum (singlet at
18.1 ppm for Me3C, and two quartets at – 4.5 and – 4.9 ppm for the two MeSi) are
characteristic for compounds containing the dimethyl-tert-butylsilyloxy group.
For the desired modification of the steroid moiety, it was necessary to shift the
double bond from the C(5)–C(6) to the C(4)–C(5) position. This was done by sapo-
nification of the 3-acetoxy derivative 3 with a 5 % methanolic solution of potassium
hydroxide to give the alcohol 4 (in 95.6 % yield). The Oppenauer oxidation of the al-
cohol in dry toluene and cyclohexanone in the presence of aluminium isopropoxide
gave the conjugated 3-oxo-4-derivative 5 (in 93.6 % yield). Its reduction with a
methanolic sodium borohydride solution gave the allylic alcohol 6 (in 88.6 % yield),
which upon acetylation with acetic anhydride in pyridine at room temperature, was
converted to the required intermediate, the 3-acetoxy derivative 7 (in 86.7 % yield).
The spectral and analytical data obtained for the compounds 2–7 were in com-
plete agreement with their structures presented in Scheme 1 (see Experimental).
The further steps leading from the allylic acetate 7 to the 5-aza derivative 15 (shown
in Scheme 2) are based on the approach designed by Rodewald et al. for the synthesis of
5-azasteroids of the cholestane3 and androstane4 series. It consisted of the following.
Cleavage of the olefinic 4-double bond in the 3-acetoxy derivative 7 by
ozonolysis in dichloromethane solution at – 75 ºC, followed by reductive opening of
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Scheme 1. a. NaBH4/MeOH, b. TBDMSCl, imidazole, dimethyl formamide, c. KOH/MeOH,
d. Oppenauer oxidation, e. NaBH4/MeOH, f. Ac2O/Py.
the ozonide bridge with dimethyl sulfide, affording the 4,5-seco-ketoaldehyde 8 (in
99.5 % yield). This product was treated with 5 % aqueous potassium permanganate so-
lution in tert-butylalcohol to give B-nor-4,5-seco-(3S)-acetoxy-17-dimethyl-tert-bu-
tylsilyloxyandrostan-5-on-4-oic acid 9 which was isolated as an oil (in 97.8 % yield).
Due to the instability of the ketoaldehyde 8 and the carboxylic acid 9, they were used
in the next steps without purification. However, their spectral data were consistent with
the structures given in Scheme 2 (see Experimental).
Esterification of the acid 9 with diphenyldiazomethane and column chroma-
tography of the obtained mixture on SiO2 afforded the corresponding ester 10 (in
63.8 % yield). Its treatment with hydroxylamine hydrochloride in ethanol/pyridine
solution gave the (E)-oxime 11 (in 96.7 % yield).
In the next, step the oxime 11 was subjected to the Beckmann rearrangement
(performed in cold (–20 ºC) anhydrous diethyl ether solution with thionyl chloride)
to give a complex mixture from which, after column chromatography on silica gel,
diphenylmethyl 4,5-seco-5-aza-(3S)-acetoxy-17-dimethyl-tert-butylsilyloxyan-
drostan-6-on-4-oate 12 was obtained (however in only 34.1 % yield). The low
yield of the lactam 12 is partly due to a competing process by which the 1(10)-un-
saturated cyanide of the partial structure i (Scheme 3) is formed (in about 20 %
yield).
Upon saponification of the lactam 12, both the acetoxy and benzhydrilic
groups were removed, producing (3S)-hydroxy-17-dimethyl-tert-butylsilyloxy-4,5-se-
co-5-azaandrostan-6-on-4-oic acid (13) (in 94.8 % yield). Treatment of a cooled
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Scheme 2. a. 1. O3, 2. (CH3)2S, b. KMnO4,
tBuOH/NaH2PO4, c. Ph2CN2, d. NH2OH/EtOH, e.
SOCl2/ether, f. 1. KOH/MeOH, 2. HCl, g. Ac2O/Py, h. LiAlH4/dioxane.
solution (0 ºC) of the acid 13 with acetic anhydride in pyridine, resulted in
simultaneous cyclization and acetylation affording 17-dimethyl-tert-butylsilylo-
xy-5-azaandrostane-4,6-dion-3-yl acetate 14 (in 84.5 %). Reduction of the diimi-
de 14 was performed with an excess of lithium aluminium hydride in boiling
dioxane. Under these conditions, both the C-4 and C-6 oxo functions were reduced
to methylene groups and the 3-acetoxy function to the 3-hydroxyl group, af-
fording the desired 17-dimethyl-tert-butylsilyloxy-5-azaandrostan-3-ol (15) in
90.7 % yield (and after recrystallization from acetone/methanol in 76.5 % yield).
Analytical (C24H45O2NSi) and spectral data (IR,
1H- and 13C-NMR, see Ex-
perimental) of the obtained 5-aza derivative 15 showed that protection of the
17-hydroxyl was preserved during all steps of the synthesis. The total yield of 15
starting from compound 1 was about 9 %.
EXPERIMENTAL
General
Column chromatography: silica gel 0.04–0.063 mm. TLC: control of reactions and separation
of products on silica gel G (Stahl), detection with aq. 50 % H2SO4 soln. M.p.: uncorrected. IR spec-
tra: Perkin-Elmer-337 and Varian Gemini FT- 80A spectrophotometers;  in cm–1. NMR spectra:
aVarian Gemini 200 and bVarian Gemini FT-80 (1H at 200 and 80 MHz; 13C at 50 MHz); CDCl3
soln. at r.t.; SiMe4 as internal standard;  in ppm, J in Hz. Mass spectra: Finnigan-MAT 8230; m/z
(rel. intensity in %); ionization energy 70 eV.
B-Nor-17-oxoandrost-5-en-3-yl acetate (1)1,2
M.p. 134–135 ºC (lit.2 m.p. 135–136 ºC), D = – 43.5 (c = 1.0, CHCl3); lit.
2
D = – 50 	 2 (c
= 2.4, CHCl3). IR (neat): 1745, 1244, 1049.
1H-NMRa: 0.91 (s, 3H, Me(18)), 0.92 (s, 3H, Me(19)),
2.05 (s, 3H, AcO), 2.45 (2 
 m, 2H), 2.66 (ddd, 1H, J = 13.6, 4.6, 2.0 Hz, H

–C(4)), 4.64 (m, 1H,
H–C(3)), 5.47 (br.s, 1H, H–C(6)). 13C-NMR: 220.1 (s, C(17)), 170.3 (s, MeCOO), 148.7 (s, C(5)),
124.1 (d, C(6)), 73.3 (d, C(3)), 62.3 (d, C(9)), 49.4 (d, C(14)), 49.1 (s, C(13)), 45.5 (d, C(8)), 44.5 (s,
C(10)), 36.6 (t, C(1)), 35.6 (t, C(16)), 32.6 (t, C(4)), 31.6 (t, C(12)), 27.7 (t, C(2)), 22.2 (t, C(15)),
21.2 (q, MeCOO), 19.9 (t, C(11)), 14.8 (q, C(19)), 13.9 (q, C(18)). Anal: calcd. for C20H28O3
(316.444): C 75.91, H 8.92; found: C 75.68, H 9.00.
Sodium borohydride reduction of B-nor-17-oxoandrost-5-en-3-yl acetate (1)
To a stirred soln. of 1 (50.0 g) in MeOH (350 ml) cooled in an ice-water bath, NaBH4 (4.0 g)
was added portion-wise during 20 min. The mixture was poured into vigorously stirred ice cold wa-
ter acidified with acetic acid. The precipitate was filtered off, thoroughly washed with water and
air-dried to give B-nor-17-hydroxy-androst-5-en-3-yl acetate (2) (50.0 g, 99.5 %), which was
recrystallized from acetone/methanol (47.6 g, 94.6 %). M.p. 148–150 ºC (lit.5 m.p. 151–152 ºC). IR
(KBr): 3300, 1735, 1240, 1054, 1036. 1H-NMRa: 0.77 (s, 3H, Me-(18)), 0.90 (s, 3H, Me-(19)), 2.04
(s, 3H, AcO), 2.63 (ddd, 1H, J = 13.6, 5.0, 2.0 Hz, H

–C(4)), 3.69 (t, 1H, J = 7.6 Hz, H–C(17)), 4.63
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Scheme 3.
(m, 1H, H–C(3)), 5.38 (br.s, 1H, H–C(6)). 13C-NMR: 170.6 (s, MeCOO), 148.0 (s, C(5)), 125.6 (d,
C(6)), 81.3 (d, C(17)), 73.6 (d, C(3)), 62.4 (d, C(9)), 49.1 (d, C(14)), 46.1 (d, C(8)), 44.9 (s, C(13)),
44.6 (s, C(10)), 36.9 (t, C(1)), 36.8 (t, C(16)), 32.7 (t, C(4)), 30.6 (t, C(12)), 27.9 (t, C(2)), 23.7 (t,
C(15)), 21.3 (q, MeCOO), 20.5 (t, C(11), 14.9 (q, C(19)), 11.3 (q, C(18)). Anal: calcd. for C20H30O3
(381.460): C 75.43, H 9.50; found: C 75.37, H 9.49.
Dimethyl-tert-butylsilylation of B-nor-17-hydroxy-androst-5-en-3-yl acetate (2)
To a stirred soln. of 2 (47.0 g) in dimethylformamide (330 ml) cooled in an ice-water bath,
dimethyl-tert-butylsilyl chloride (34.04 g) and imidazole (31.6 g) were added. The stirring was contin-
ued first at r.t. (30 min) and then at 45–50 ºC until consumption of the substrate (TLC control) (2 h).
The mixture was poured into crushed ice-water ( 2 l) with vigorous stirring. The precipitate was fil-
tered off, thoroughly washed with water and air-dried to give B-nor-17-dimethyl-tert-butylsilyloxy-
androst-5-en-3-yl acetate (3) (62.0 g, 97.1 %). M.p. 83–87 ºC. D = – 76.8 (c = 1.0, CHCl3). IR
(KBr): 1736, 1242, 1129, 1088, 1033, 837, 777. 1H-NMRb: 0.70 (s, 3H, Me(18)), 0.86 (s, 12H, Me3C,
Me(19)), 2.01 (s, 3H, AcO), 2.62 (dd, 1H, J = 13.6, 5.0 Hz, H

–C(4)), 3.58 (m, 1H, H–C(17)), 4.60 (m,
1H, H–C(3)), 5.34 (br.s, 1H, H–C(6)). 13C-NMR: 170.6 (s, MeCOO), 147.9 (s, C(5)), 125.8 (d, C(6)),
81.2 (d, C(17)), 73.7 (d, C(3)), 62.7 (d, C(9)), 48.8 (d, C(14)), 46.3 (d, C(8)), 45.3 (s, C(13)), 44.6 (s,
C(10)), 37.3 (t, C(1)), 36.9 (t, C(16)), 32.7 (t, C(4)), 31.1 (t, C(12)), 28.0 (t, C(2)), 25.8 (q, Me3C), 23.9
(t, C(15)), 21.4 (q, MeCOO), 20.6 (t, C(11)), 18.1 (s, Me3C), 15.0 (q, C(19)), 11.5 (q, C(18)), –4.5 (q,
MeSi), –4.9 (q, MeSi). Anal: calcd. for C26H44O3Si (432.724): C 72.17, H 10.25; found: C, 72.03, H,
10.34.
Saponification of B-nor-17-dimethyl-tert-butylsilyloxyandrost-5-en-3-yl acetate (3)
A soln. of 3 (105.5 g) in MeOH (600 ml) and 5 % methanolic KOH (100 ml) was refluxed for 1 h.
After cooling at r.t., the mixture was diluted with water. The precipitate was filtered off, thoroughly
washed with water and air-dried to give B-nor-17-dimethyl-tert-butylsilyloxyandrost-5-en-3-ol (4)
(91.1 g, 95.6 %). M.p. 141–143 ºC. D = – 58.0 (c = 1.0, CHCl3). IR (KBr): 3412, 3267, 1461, 1251,
1131, 1106, 1097, 1088, 1063, 1044, 858, 835, 774. 1H-NMRb: 0.72 (s, 3H, Me(18)), 0.86 (s, 12H,
Me3C, Me(19)), 2.58 (dd, 1H, J = 13.6, 5.2 Hz, H–C(4)), 3.56 (2 
 m, 2H, H–C(3), H–C(17)), 5.32
(br.s, 1H, H–C(6)). 13C-NMR: 149.2 (s, C(5)), 124.9 (d, C(6)), 81.3 (d, C(17)), 71.7 (d, C(3)), 62.8 (d,
C(9)), 49.0 (d, C(14)), 46.3 (d, C(8)), 45.3 (s, C(13)), 44.6 (s, C(10)), 37.4 (t, C(1)), 37.2 (t, C(16)),
36.6 (t, C(4)), 32.0 (t, C(12)), 31.1 (t, C(2)), 25.8 (q, Me3C), 23.9 (t, C(15)), 20.6 (t, C(11)), 18.1 (s,
Me3C), 15.1 (q, C(19)), 11.5 (q, C(18)), –4.5 (q, MeSi), –4.9 (q, MeSi)). Anal: calcd. for C24H42O2Si
(390.686): C 73.78, H 10.84; found: C 73.76, H 10.96.
Oppenauer oxidation of B-nor-17-dimethyl-tert-butylsilyloxyandrost-5-en-3-ol (4)
To a distilling soln. of 4 (91.0 g) in dry toluene (2 l) and cyclohexanone (500 ml), a soln. of
Al-isopropoxide (28 g) in toluene (400 ml) was slowly added through a dropping funnel at a rate which
corresponded to the rate of solvent distillation. When the addition was completed and the substrate con-
sumed (TLC control), the distillation was continued until ca. 1200 ml solvent had been distilled off. The
rest was transferred to a separatory funnel, treated with a saturated aq. K,Na-tartrate soln. (400 ml) and
after vigorous shaking the separated aq. layer was discarded. The organic layer was diluted with CHCl3,
washed with water, dried (Na2SO4), filtered off and evaporated to dryness under reduced pressure to give
B-nor-17-dimethyl-tert-butylsilyloxyandrost-4-en-3-one (5) (84.7 g, 93.6 %), which was recrystallized
from MeOH (76.9 g, 84.9 %). M.p. 101–103 ºC. D
25 = –0.60 (c = 1.0, CHCl3). IR (KBr): 1673, 1620,
1262, 1251, 1108, 1097, 1077, 879, 841, 777. 1H-NMRa: 0.013 (s, 3H, Me–Si), 0.018 (s, 3H, Me–Si),
0.76 (s, 3H, Me(18)), 0.89 (s, 9H, Me3C), 1.08 (s, 3H, Me(19)), 3.61 (t, 1H, J = 7.8 Hz, H–C(17)), 5.78
(br.s, 1H, H–C(4)). 13C-NMR: 199.6 (s, C(3)), 179.0 (s, C(5)), 122.5 (d, C(4)), 81.1 (d, C(17)), 58.4 (d,
C(9)), 50.3 (d, C(14)), 45.0 (s, C(13)), 43.8 (s, C(10)), 38.4 (d, C(8)), 36.6 (t, C(2)), 35.2 (t, C(16)), 34.2
(t, C(1)), 33.5 (t, C(6)), 30.9 (t, C(12)), 25.8 (q, Me3C), 23.9 (t, C(15)), 20.4 (t, C(1)), 18.0 (s, Me3C),
17.4 (q, C(19)), 11.6 (q, C(18)), –4.6 (q, MeSi), –4.9 (q, MeSi). Anal: calcd. for C24H40O2Si (388.670):
C 74.17, H 10.37; found: C 74.28, H 10.22.
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Sodium borohydride reduction of B-nor-17-dimethyl-tert-butylsilyloxyandrost-4-en-3-one (5)
A solution of 5 (90.0 g) in MeOH (800 ml) was reduced with NaBH4 (11 g) at r.t. (TLC control)
and the mixture worked up as previously described. The isolated crystalline solid (88.0 g, 97.3 %) was
recrystallized twice from MeOH to give B-nor-17-dimethyl-tert-butylsilyloxyandrost-4-en-3-ol (6)
(80.2 g, 88.6 %). M.p. 123–126 ºC. IR (KBr): 3416, 1473, 1251, 1155, 1102, 877, 838, 774. 1H-NMRa:
0.000 (s, 3H, Me–Si), 0.005 (s, 3H, Me–Si), 0.73 (s, 3H, Me(18)), 0.88 (s, 9H, Me3C), 0.96 (s, 3H,
Me(19)), 2.43 (dd, 1H, J = 17.4, 9.6 Hz, H

–C(6)), 3.57 (t, 1H, J = 7.6 Hz, H–C(17)), 4.26 (m, 1H,
H–C(3)), 5.30 (s, 1H, H–C(4)). 13C-NMR: 152.9 (s, C(5)), 121.6 (d, C(4)), 81.3 (d, C(17)), 68.8 (d,
C(3)), 59.2 (d, C(9)), 50.5 (d, C(14)), 45.1 (s, C(13)), 42.1 (s, C(10)), 37.9 (d, C(8)), 36.9 (t, C(2)), 35.3
(t, C(16)), 31.9 (t, C(1)), 30.9 (t, C(6)), 29.3 (t, C(12)), 25.8 (q, Me3C), 24.0 (t, C(15)), 20.5 (t, C(11),
18.5 (q, C(19)), 18.0 (s, Me3C), 11.7 (q, C(18)), –4.6 (q, MeSi), –5.0 (q, MeSi). Anal: calcd. for
C24H42O2Si (390.686): C 73.78, H 10.84; found: C 73.75, H 10.67.
Acetylation of B-nor-17-dimethyl-tert-butylsilyloxyandrost-4-en-3-ol (6)
A solution of 6 (80.0 g) in pyridine (425 ml) was acetylated with acetic anhydride (275 ml) at
r.t. for 16 h. The mixture was poured into crushed ice-water under stirring. The precipitate was fil-
tered off, thoroughly washed with water and air-dried to give B-nor-17-dimethyl-tert-butylsilylo-
xyandrost-4-en-3-yl acetate (7) (87.3 g, 98.5 %), which was recrystallized from acetone/methanol
(76.8 g, 86.7 %). M.p. 72–73 ºC. D = –62.3 (c = 1.0, CHCl3). IR (KBr): 1736, 1240, 1101, 907,
879, 838,. 778. 1H-NMRb: 0.00 (s, 6H, Me2Si), 0.72 (s, 3H, Me(18)), 0.88 (s, 9H, Me3C), 0.98 (s,
3H, Me(19)), 2.05 (s, 3H, AcO), 3.58 (t, 1H, J = 7.8 Hz, H–C(17)), 5.26 (br.s, 1H, H–C(4)), 5.35 (m,
1H, H–C(3)). 13C-NMR: 171.1 (s, MeCOO), 155.5 (s, C(5)), 117.3 (d, C(4)), 81.2 (d, C(17)), 71.2
(d, C(3)), 59.1 (d, C(9)), 50.5 (d, C(14)), 45.1 (s, C(13)), 42.0 (s, C(10)), 37.9 (d, C(8)), 36.9 (t,
C(2)), 35.2 (t, C(16)), 32.2 (t, C(1)), 30.9 (t, C(6)), 25.8 (q, Me3C), 24.9 (t, C(12)), 24.0 (t, C(15)),
21.4 (MeCOO), 20.1 (t, C(11)), 18.5 (q, C(19)), 18.0 (s, Me3C), 11.7 (q, C(18)), –4.6 (q, MeSi), –4.9
(q, MeSi). Anal: calcd. for C26H44O3Si (432.724): C 72.17, H 10.25; found: C 71.96, H 9.89.
Ozonolysis of B-nor-17-dimethyl-tert-butylsilyloxyandrost-4-en-3-yl acetate (7) (reductive pro-
cedure)
A solution of 7 (12.5 g) in CH2Cl2 (365 ml) and MeOH (1.82 ml) was ozonized at –75 ºC till
blue color appeared (7.7 h). While still at –75 ºC, the solution was flushed with argon for 45 min
and treated with dimethyl sulfide (13 ml). The mixture was left at –75 ºC for 1 h and at 0 ºC for 4 h.
Then it was transferred to a separatory funnel, diluted with CH2Cl2 (200 ml), washed with water,
saturated aq. NaHCO3 soln., water, dried (Na2SO4) and evaporated to dryness affording B-nor-4,5-se-
co-4,5-dioxo-17-dimethyl-tert-butylsilyloxyandrostan-(3S)-yl acetate (8) (13.35 g, 99.5 %), as an
oil. It was used in the next step without purification.* IR (neat): 1738, 1249, 1134, 1101, 1075, 1044,
836, 775, 758. 1H-NMRa: –0.01 (s, 3H, Me–Si), – 0.03 (s, 3H, Me–Si), 0.78 (s, 3H, Me(18)), 0.89 (s,
9H, Me3C), 0.90 (s, 3H, Me(19)), 2.17 (s, 3H, AcO), 2.34 (dd, 1H, J = 15.6, 4.4 Hz, H–C(6)), 3.63
(t, 1H, J = 7.8 Hz, H–C(17)), 4.91 (dd, 1H, J = 7.6, 4.2 Hz, H–C(3)), 9.49 (s, 1H, HCO). 13C-NMR:
221.9 (s, C(5)), 198.1 (d, C(4)), 170.5 (s, MeCOO), 81.0 (d, C(17)), 78.2 (d, C(3)), 52.1 (d, C(9)),
50.1 (d, C(14)), 50.0 (s, C(13)), 44.7 (s, C(10)), 42.9 (t, C(2)), 36.6 (t, C(16)), 36.5 (d, C(8)), 31.3 (t,
C(1)), 30.7 (t, C(6)), 25.7 (q, Me3C), 23.9 (t, C(12)), 23.6 (t, C(15)), 20.7 (q, MeCOO), 20.4 (t,
C(11)), 17.9 (s, Me3C), 17.5 (q, C(19)), 11.5 (q, C(18)), –4.7 (q, MeSi), –5.0 (q, MeSi). C26H44O5Si
(464.724). CI-MS: 465 (M + 1, 12 %), 405 (465 – CH3COOH, 100 %).
Potassium permanganate oxidation of B-nor-4,5-seco-4,5-dioxo-17-dimethyl-tert-butylsilyloxya-
ndrostan-(3S)-yl acetate (8)
To a solution of 8 (13.30 g) in tert-BuOH (172 ml) and aq. 5 % Na2HPO4 soln. (115 ml), an aq.
1 M KMnO4 soln. (172 ml) was gradually added with vigorous stirring at r.t. After 45 min (TLC con-
trol), the reaction was quenched with cold (0 ºC) dilute HCl (to pH 3). The mixture was extracted
with diethyl ether, the organic layer washed with saturated aq. NaCl soln. until neutral, dried
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(Na2SO4) and evaporated to dryness under reduced pressure to give B-nor-4,5-seco-(3S)-aceto-
xy-17-dimethyl-tert-butylsilyloxyandrostan-5-on-4-oic acid (9) (13.45 g, 97.8 %), as an oil. It was
used in the next step without purification.* IR (neat): 3650–3200, 1740, 1250, 1135, 1075, 836, 776.
1H-NMRa: 0.02 (s, 3H, Me–Si), 0.03 (s, 3H, Me–Si), 0.78 (s, 3H, Me(18)), 0.89 (s, 9H, Me3C), 0.92
(s, 3H, Me(19)), 2.14 (s, 3H, AcO), 2.36 (dd, 1H, J = 15.6, 4.4 Hz, H

–C(6)), 3.64 (t, 1H, J = 7.2 Hz,
H–C(17)), 4.94 (dd, 1H, J = 7.4, 4.4 Hz, H–C(3)), 8.20–8.6 (br.s, 1H, COOH). 13C-NMR: 222.5 (s,
C(5)), 174.9 (s, COOH), 170.6 (s, MeCOO), 81.0 (d, C(17)), 71.9 (d, C(3)), 52.3 (d, C(9)), 50.1 (d,
C(14)), 50.0 (s, C(13)), 44.7 (s, C(10)), 43.0 (t, C(2)), 36.7 (t, C(16)), 36.5 (d, C(8)), 31.6 (t, C(1)),
30.7 (t, C(6)), 26.0 (t, C(12)), 25.7 (q, Me3C), 23.9 (t, C(15)), 20.8 (q, MeCOO), 20.5 (t, C(11)), 17.9
(s, Me3C), 17.5 (q, C(19)), 11.5 (q, C(18)), –4.7 (q, MeSi), –5.0(q, MeSi). C26H44O6Si (480.724).
CI-MS: 481 (M + 1, 100 %), 421 (M – CH3COOH, 21 %).
Esterification of B-nor-4,5-seco-(3S)-acetoxy-17-dimethyl-tert-butylsilyloxyandrostan-5-on-4-oic
acid (9) with diphenyldiazomethane
A stirred solution of 9 (13.40 g) in dry benzene (250 ml) was treated with diphenyldiazomethane
(5 g) in benzene (50 ml) dropwise at r.t. until a persistent violet colour was obtained. The mixture was
evaporated to dryness and the residue chromatographed on SiO2 column (450 g). Elution with ben-
zene/EtOAc (94:6 and 95:5) eluted diphenylmethyl B-nor-4,5-seco-(3S)-acetoxy-17-dimethyl-te-
rt-butylsilyloxyandrostan-5-on-4-oate (10) (11.5 g, 63.8 %), as an oil. IR (neat): 1746, 1472, 1455,
1250, 1100, 1075, 836, 758, 701. 1H-NMRa: 0.025 (s, 3H, Me–Si), 0.037 (s, 3H, Me–Si), 0.76 (s, 3H,
Me(18)), 0.82, (s, 3H, Me(19)), 0.90 (s, 9H, Me3C), 2.11 (s, 3H, AcO), 2.29 (dd, 1H, J = 16.4, 5.4 Hz,
H

–C(6)), 3.61 (t, 1H, J = 7.2 Hz, H–C(17)), 5.06 (dd, 1H, J = 7.0, 5.2 Hz, H–C(3)), 7.00 (s, 1H,
(OCH(Ph)2), 7.26–7.41 (m, 10H, arom.).
13C-NMR: 221.9 (s, C(5)), 170.4 (s, MeCOO), 169.2 (s,
COOCHPh2), 139.5 (s, arom. C–CH), 139.3 (s, arom. C–CH), 129.6–126.9 (doublets, arom CH), 81.1
(d, C(17)), 77.8 (d, OCHPh2), 72.4 (d, C(3)), 52.5 (s, C(9)), 50.2 (d, C(14)), 49.8 (s, C(13)), 44.7 (s,
C(10)), 43.0 (t, C(2)), 36.8 (t, C(16)), 36.6 (d, C(8)), 31.4 (t, C(1)), 30.8 (t, C(6)), 26.0 (t, C(12)), 25.8
(q, Me3C), 24.0 (t, C(15)), 20.7 (q, MeCOO), 20.6 (t, C(11)), 18.0 (s, Me3C), 17.4 (q, C(19)), 11.6 (q,
C(18)), – 4.6 (q, MeSi), – 4.9 (q, MeSi). Anal: calcd. for C39H54O6Si (646.947): C 72.41, H 8.41;
found: C 72.29, H 8.59. CI-MS: m/z = 647 (M + 1).
Oximation of diphenylmethyl B-nor-4,5-seco-(3S)-acetoxy-17-dimethyl-tert-butylsilyloxyandro-
stan-5-on-4-oate (10)
A solution of 10 (9.20 g) and hydroxylamine hydrochloride (9.20 g) in ethanol (150ml) and
pyridine (36 ml) was heated at reflux for 1.5 h. The solvent was removed by distillation in vacuo and
the residue diluted with diethyl ether. The ethereal layer was thoroughly washed with water, dried
(Na2SO4) and evaporated to dryness. The resulting product was chromatographed on SiO2 column
(100 g). Elution with benzene/EtOAc (95:5) afforded diphenylmethyl B-nor-4,5-seco-(3S)-ace-
toxy-17-dimethyl-tert-butylsilyloxyandrostan-5-on-4-oate oxime (11) (9.1 g, 96.7 %), as an oil.+
IR (neat): 3442, 1748, 1249, 1103, 1079, 836, 776, 700. 1H-NMRa: 0.019 (s, 3H, Me–Si), 0.030 (s,
3H, Me–Si), 0.71 (s, 3H, Me(18)), 0.89 (s, 9H, Me3C), 0.91 (s, 3H, Me(19)), 2.10 (s, 3H, AcO), 3.59
(t, 1H, J = 7.6 Hz, H–C(17)), 5.06 (t, 1H, J = 5.6 Hz, H–C(3)), 6.91 (s, 1H, OCHPh2), 7.24–7.34 (m,
10H, arom.), 7.82 (br.s, 1H, NOH). 13C-NMR: 170.6 (s, MeCOO), 170.0 (s, C(5)), 169.4 (s,
COOCHPh2), 139.7 (s, arom. C–CH), 139.5 (s, arom, C–CH), 128.5–126.9 (doublets, arom. CH),
81.2 (d, C(17)), 77.6 (d, COOCHPh2), 72.7 (d, C(3)), 53.6 (d, C(9)), 50.2 (d, C(14)), 45.7 (s, C(13)),
44.8 (s, C(10)), 37.6 (d, C(8)), 36.7 (t, C(2)), 33.0 (t, C(16)), 31.2 (t, C(1)), 30.9 (t, C(6)), 26.2 (t,
C(12)), 25.8 (q, Me3C), 23.8 (t, C(15)), 21.2 (q, MeCOO), 20.5 (t, C(11)), 18.1 (s, Me3C), 11.6 (q,
C(18)), – 4.6 (q, MeSi), – 4.9 (q, MeSi).Anal: calcd. for C39H55NO6Si (661.962): C 70.76, H 8.38;
found: C 71.19, H 8.77. CI-MS: m/z = 662 (M + 1, 30 %).
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* For analyses a small amount of this product was chromatographed on a SiO2 column.
+ For analysis a small amount of this product was rechromatographed.
Beckmann rearrangement of diphenylmethyl B-nor-4,5-seco-(3S)-acetoxy-17-dimethyl-tert-butylsi-
lyloxyandrostan-5-on-4-oate oxime (11)
To a cooled solution (–20 ºC) of 11 (9.05 g) in dry diethyl ether (500 ml), a soln. of freshly dis-
tilled SOCl2 (24 ml) in dry diethyl ether (250 ml) was added dropwise under stirring. The mixture
was stirred for an additional 30 min, poured into crushed ice, carefully neutralized with saturated aq.
NaHCO3 soln. and extracted with diethyl ether. The ethereal layer was dried and evaporated to give
an oily mixture (about 9 g), which was separated by column chromatography on silica gel (300 g).
Elution with benzene afforded a mixture (1.75 g,  20 %) in which the undesired cyano derivative
prevailed (IR: 2240 cm
-1 (CN); 1H-NMR:  = 1.60 ppm (Me at the olefinic double bond),  5.00
(olefinic proton)).
*
Elution with benzene/EtOAc (95:5, 90:10 and 85:15) gave a complex mixture
(2.6 g), which was not further investigated. Elution with benzene/Et2O gave diphenylmethyl
4,5-seco-5-aza-(3S)-acetoxy-17-dimethyl-tert-butylsilyloxyandrostan-6-on-4-oate (12) (3.09 g,
34.1 %), as an oil. IR (neat): 3194, 1747, 1660, 1451, 1377, 1249, 1198, 1092, 876, 837, 757, 700.
1H-NMRa: 0.014 (s, 3H, Me–Si), 0.023 (s, 3H, Me–Si), 0.70 (s, 3H, Me(18)), 0.89 (s, 9H, Me3C),
1.01 (s, 3H, Me(19)), 2.13 (s, 3H, AcO), 3.56 (t, 1H, J = 8.4 Hz, H–C(17)), 5.13 (t, 1H, J = 5.8 Hz,
H–C(3)), 5.39 (s, 1H, NH), 6.95 (s, 1H, COOCHPh2), 7.30–7.40 (m, 10H, arom.).
13C-NMR: 171.7
(s, C(6)), 170.3 (s, MeCOO), 168.9 (s, COOCHPh2), 139.5 (s, arom. C–CH), 139.1 (s, arom.
C–CH), 128.7–126.9 (doublets, arom. CH), 81.2 (d, C(17)), 77.9 (d, COOCHPh2) 71.7 (d, C(3)),
57.3 (s, C(10)), 50.3 (d, C(14)), 43.6 (d, C(9)), 43.1 (s, C(13)), 36.6 (t, C(12)), 36.3 (t, C(7)), 35.2 (t,
C(1)), 31.3 (d, C(8)), 30.6 (t, C(16)), 25.8 (q, Me3C), 25.7 (q, C(19)), 24.7 (t, C(15)), 23.1 (t, C(2)),
21.2 (t, C(11)), 20.6 (q, MeCOO), 18.0 (s, Me3C), 11.2 (q, C(18)), – 4.6 (q, MeSi), – 4.9 (q, MeSi).
Anal: calcd. for C39H55NO6Si (661.962): C 70.76, H 8.38, N 2.12; found: C 70.81, H, 7.98, N 2.07.
CI-MS: m/z = 662 (M + 1).
Saponification of diphenylmethyl 4,5-seco-5-aza-(3S)-acetoxy-17-dimethyl-tert-butylsilyloxyan-
drostan-6-on-4-oate (12)
A solution of 12 (3.0 g) in MeOH (100 ml) and 5 % methanolic potassium hydroxide (25 ml)
was refluxed for 2 h (TLC control) and poured onto crushed ice. The mixture was transferred to a
separatory funnel and washed with diethyl ether. The aqueous layer was cooled to – 10 ºC, acidified
with 10 % hydrochloric acid to pH 1 and extracted with CH2Cl2. The organic layer was washed with
water, dried (Na2SO4) and evaporated to dryness to give (3S)-hydroxy-17-dimethyl-tert-bu-
tylsilyloxy-4,5-seco-5-aza-androstan-6-on-4-oic acid (13) (1.95 g, 94.8 %), which was used in the
next step without purification. IR (neat): 3600–3150, 1708, 1641, 1451, 1407, 1251, 1142, 875, 837,
816, 774, 668. 1H-NMR: 0.00 (s, 3H, Me–Si), 0.010 (s, 3H, Me–Si), 0.72 (s, 3H, Me(18)), 0.88 (s,
9H, Me3C), 1.26 (s, 3H, Me(19)), 3.58 (2 
 m, 2H, H–C(3), H–C(17)), 5.15 (br.s, 2H, NH,
HO–C(3)), 7.45 (br. m, 1H, COOH). C24H45NO5Si (453.701). CI-MS: m/z = 454 (M + 1, 50 %).
Cyclization of (3S)-hydroxy-17-dimethyl-tert-butylsilyloxy-4,5-seco-5-azaandrostan-6-on-4-oic acid (13)
To a cold (0 ºC) solution of 13 (1.90 g) in pyridine (50 ml), acetic anhydride (25 ml) was added
and the mixture left overnight in a refrigerator. Then it was poured onto crushed ice and extracted
with CH2Cl2. The organic layer was washed with water, dried (Na2SO4) and evaporated to dryness
leaving an oil (about 2 g) which was recrystallized from methanol to give 17-dimethyl-te-
rt-butylsilyl-5-azaandrostane-4,6-dion-3-yl acetate (14) (1.69 g, 84.5 %). M.p. 166–168 ºC. D =
– 53.4 (c = 1.0, CHCl3). IR (KBr): 1773, 1757, 1669, 1474, 1461, 1371, 1252, 1229, 1137, 1099,
1079, 877, 835, 775. 1H-NMRb: 0.70 (s, 3H, Me(18)), 0.85 (s, 9H, Me3C), 1.28 (s, 3H, Me(19)),
2.23 (s, 3H, AcO), 3.56 (t, 1H, J = 8.0 Hz, H–C(17)), 5.25 (m, 1H, H–C(3)). 13C-NMR: 174.5, 173.3
(two s, C(4), C(6)), 170.6 (s, MeCOO), 81.2 (d, C(17)), 71.5 (d, C(3)), 58.3 (s, C(10)), 50.2 (d,
C(14)), 43.6 (d, C(9)), 43.2 (s, C(13)), 36.2 (t, C(12)), 35.4 (t, C(7)), 35.0 (t, C(1)), 30.7 (d, C(8)),
25.8 (q, Me3C), 25.0 (q, C(19)), 24.8 (t, C(15)), 23.1 (t, C(2)), 21.3 (t, C(11)), 20.7 (q, MeCOO),
18.0 (s, Me3C), 11.2 (q, C(18)), – 4.6 (q, MeSi), – 4.9 (q, MeSi). Anal: calcd. for C26H43NO5Si
(477.723): C 65.37, H 9.07, N 2.93; found: C 65.24, H 9.29, N 3.16. CI-MS: m/z = 478 (M + 1).
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* This compound was not properly purified for a correct analysis.
Lithium aluminium hydride reduction of 17-dimethyl-tert-butylsilyl-5-azaandrostane-4,6-dion-3-yl
acetate (14)
To a refluxed suspension of LiAlH4 (12 g) in dioxane (distilled over Na) (190 ml), a soln. of 14
(1.90 g) in dry dioxane (190 ml) was dropwise added during 3 h, and the heating continued for an ad-
ditional 14 h. The usual alkaline work-up afforded a crude reaction product (1.47 g, 90.7 %) which
was recrystallized from acetone/methanol to give 17-dimethyl-tert-butylsilyloxy-5-azaandro-
stan-3-ol (15) (1.24 g, 76.5 %). M.p. 158–159 ºC. D = + 4.3 (c = 1.0, CHCl3). IR (KBr): 3338,
1473, 1390, 1374, 1250, 1156, 1133, 1095, 1070, 896, 834, 775. 1H-NMRb: 0.71 (s, 3H, Me(18)),
0.86 (s, 9H, Me3C), 0.92 (s, 3H, Me(19)), 2.20–2.80 (m, 4H, H2C(4), H2C(6)), 3.58 (t, 1H, J = 8.0
Hz, H–C(17)), 3.75 (m, 1H, H–C(3)). 13C-NMR: 81.6 (d, C(17)), 68,0 (d, C(3)), 57.1 (t, C(4)), 55.4
(s, C(10)), 53.3 (d, C(14)), 50.1 (d, C(9)), 49.8 (t, C(6)), 43.1 (s, C(13)), 37.0 (t, C(12)), 36.1 (t,
C(1)), 34.3 (d, C(8)), 30.9 (t, C(7)), 30.6 (t, C(16)), 29.9 (t, C(15)), 25.8 (q, Me3C), 23.2 (t, C(2)),
21.7 (t, C(11)), 18.0 (s, Me3C), 11.3 (q, C(18)), 7.12 (q, C(19)), – 4.6 (q, MeSi), – 4.9 (q, MeSi)).
Anal: calcd. for C24H45NO2S (407.717): C 70.70, H, 11.12; found: C 70.88, H 11.40. CI-MS: m/z =
408 (M + 1).
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U ovom radu je opisano dobijawe 3-hidroksi-17-dimetil-tert-butilsililoksi-5-aza-
androstana (15) u 14 faza. Kao polazno jediwewe upotrebqen je B-nor-17-oksoandro-
st-5-en-3-il-acetat (1) koji je transformisan u kqu~ni intermedijer sinteze, B-nor-17-di-
metil-tert-butilsililoksiandrost-4-en-3-il-acetat (7).
(Primqeno 1. jula 2004)
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